LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Eyevensys

Non-viral technology that allows a safe local sustained production of therapeutic proteins in the eye to address a wide range of ophthalmic diseases.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Eyevensys plus 6131 other startups.

Learn More About Eyevensys

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

Competing Startups

More